EBAC

European Biotech Acquisition Corp.

USD

	Dec '21	Dec '22
account payables	57.91K -	359.54K 520.90%
accumulated other comprehensive income loss
cash and cash equivalents	868.28K -	308.49K 64.47%
cash and short term investments	868.28K -	308.49K 64.47%
common stock	127.55M -	129.26M 1.34%
deferred revenue
deferred revenue non current
deferrred tax liabilities non current
goodwill
goodwill and intangible assets
intangible assets
inventory
long term debt
long term investments		129.40M -
net debt	-868.28K -	-308.49K 64.47%
net receivables
other assets
other current assets		48.15K -
other current liabilities	447.30K -	436.03K 2.52%
other liabilities
other non current assets	127.56M -
other non current liabilities		7.75M -
othertotal stockholders equity
preferred stock
property plant equipment net
retained earnings	-6.69M -	-8.06M 20.52%
short term debt
short term investments
tax assets
tax payables		32.94K -
total assets	128.47M -	129.75M 1.00%
total current assets	916.47K -	356.64K 61.09%
total current liabilities	505.20K -	795.57K 57.48%
total debt
total investments		129.40M -
total liabilities	7.61M -	8.55M 12.31%
total liabilities and stockholders equity	128.47M -	129.75M 1.00%
total non current assets	127.56M -	129.40M 1.44%
total non current liabilities	7.11M -	7.75M 9.10%
total stockholders equity	120.86M -	121.20M 0.28%

All numbers in USD (except ratios and percentages)